In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting

European Journal of Medicinal Chemistry

Volumn 38, Issue 9, 2003, Pages 825-836

  Jasseron, S ^a   Contino Pepin C ^a   Maurizis, J C ^b   Rapp, M ^b   Pucci, B ^a  

^a UNIVERSITY OF AVIGNON   (France)

^b INSERM   (France)

Author keywords

Angiogenesis; Arabinofuranosylcytosine; Prodrugs; RGD; Telomers; Tris

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE DERIVATIVE; ESTER DERIVATIVE; IODINE 125; METHANE; N (N GAMMA ACRYLAMIDO)BUTYRAMIDO TERT BUTYL (TERT BUTYL)TYROSINE ESTER; N GAMMA ACRYLAMIDOHYDROXYSUCCINIMIDYL BUTYRIC ACID ESTER; PEPTIDE DERIVATIVE; TRIS(ACETOXYMETHYL)ACRYLAMIDOMETHANE; TRIS(HYDROXYMETHYL)ACRYLAMIDOMETHANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FOLLOW UP; IC 50; MACROMOLECULE; MELANOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SCINTIGRAPHY; TELOMERE;

EID: 0141953263     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00150-8     Document Type: Article

References (46)

1. Duncan R. Pharm. Sci. Technol. Today. 2:1999;441-449.
2. Torchilin V.P. Eur. J. Pharm. Sci. 2000;S81-S91.
3. Kerbel R.S. Carcinogenesis. 21:2000;505-515.
4. Gasparini G. Drugs. 58:1999;17-38.
5. Kerbel R.S. BioEssays. 13:1991;31-36.
6. Folkman J. J. Natl. Cancer Inst. 82:1990;4-6.
7. Folkman J. N. Engl. J. Med. 285:1971;1182-1186.
8. Ruoslahti E., Rajotte D. Annu. Rev. Immunol. 18:2000;813-827.
9. Sheu J.R., Yen M.H., Kan Y.C., Hung W.C., Chang P.T., Luk H.N. Biochim. Biophys. Acta. 1336:1997;445-454.
10. Meyer T., Hart I.R. Eur. J. Cancer. 34:1998;214-221.
11. Benjamin L.E., Golijanin D., Itin A., Pode D., Keshet E. J. Clin. Invest. 103:1999;159-165.
12. Brooks P.C., Montgomery A.M.P., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., Cheresh D.A. Cell. 79:1994;1157-1164.
13. Gutheil J.C., Campbell T.N., Pierce P.R., Watkins J.D., Huse W.D., Bodkin D.J., Cheresh D.A. Clin. Cancer Res. 6:2000;3056-3061.
14. Haubner R., Wester H.J., Burkhart F., Senekowitsch-Schmidtke R., Weber W., Goodman S.L., Kessler H., Schwaiger M. J. Nucl. Med. 42:2001;326-336.
15. Su Z.F., Liu G., Gupta S., Zhu Z., Rusckowski M., Hnatowich D.J. Bioconjugate Chem. 13:2002;561-570.
16. Arap W., Pasqualini R., Ruoslahti E. Science. 279:1998;377-380.
17. Contino-Pépin C., Maurizis J.C., Pucci B. Curr. Med. Chem. Anticancer Agent. 2:2002;645-665.
18. Baban D.F., Seymour L.W. Adv. Drug Delivery Rev. 34:1998;109-119.
19. Dvorak H.F., Nagy J.A., Dvorak J.T., Dvorak A.M. Am. J. Pathol. 133:1988;95-109.
20. Brooks P.C., Clark R.A.F., Cheresh D.A. Science. 264:1994;569-571.
21. Horton M.A. Int. J. Biochem. Cell Biol. 29:1997;721-725.
22. Ruoslahti E. Annu. Rev. Cell Dev. Biol. 12:1996;697-715.
23. Miller W.H., Keenan R.M., Willette N., Lark M.W. Drug Discovery Today. 5:2000;397-408.
24. Liekens S., De Clercq E., Neyts J. Biochem. Pharmacol. 61:2001;253-270.
25. Kolonin M., Pasqualini R., Arap W. Curr. Opin. Chem. Biol. 5:2001;308-313.
26. Goligorsky M.S., Kessler H., Romanov V.I. Nephrol. Dial. Trans. 13:1998;254-263.
27. Pierschbacher M.D., Ruoslahti E. J. Biol. Chem. 262:1987;17 294-17 298.
28. Haubner R., Gratias R., Diefenbach B., Goodman S.L., Jonczyk A., Kessler H. J. Am. Chem. Soc. 118:1996;7461-7472.
29. Haubner R., Schmitt W., Hölzemann G., Goodman S.L., Jonczyk A., Kessler H. J. Am. Chem. Soc. 118:1996;7881-7891.
30. Pucci B., Guy E., Vial-Reveillon F., Pavia A.A. Eur. Polym. J. 24:1988;1077-1086.
31. Pucci B., Maurizis J.C., Pavia A.A. Eur. Polym. J. 27:1991;1101-1106.
32. Chehade F., Maurizis J.C., Pucci B., Pavia A.A., Ollier M., Veyre A., Escaig F., Jeanguillaume C., Dennebouy R., Slodzian G., Hindie E. Cell. Mol. Biol. 42:1996;335-342.
33. Maurizis J.C., Azim M., Rapp M., Pucci B., Pavia A.A., Madelmont J.C., Veyre A. Xenobiotica. 24:1994;535-541.
34. Contino C., Ollier M., Maurizis J.C., Lacombe J.M., Pucci B. Tetrahedron Lett. 37:1996;9049-9052.
35. Contino C., Maurizis J.C., Ollier M., Rapp M., Lacombe J.M., Pucci B. Eur. J. Med. Chem. 33:1998;809-816.
36. Contino C., Maurizis J.C., Pucci B. Macromol. Chem. Phys. 200:1999;1351-1355.
37. Jasseron S., Contino-Pepin C., Maurizis J.-C., Rapp M., Pucci B. Bioorg. Med. Chem. Lett. 12:2002;1067-1070.
38. Pavia A.A., Pucci B., Riess J.G., Zarif L. Makromol. Chem. 195:1992;2505-2517.
39. Starks C.M. Free Radical Telomerizations. 1974;Academic Press, New York.
40. Brooks P.C., Clark R.A.F., Cheresh D.A. Science. 264:1994;569-571.
41. Friedlander M., Theesfeld C.L., Sugita M., Fruttiger M., Thomas M.A., Chang S., Cheresh D.A. Proc. Natl. Acad. Sci. USA. 93:1996;9764-9769.
42. Freshney R.I. Measurement of Cytotoxicity and Viability in Culture of Animals Cells. 22nd ed. 1987;245-256 Liss R.A., Inc, New York.
43. Bourut C., Chenu E., Godenèche D., Madelmont J.C., Maral R., Mathé G., Meyniel G. Br. J. Pharmacol. 89:1986;539-546.
44. R.I. Geran, N.H. Greenberg, M.M. MacDonald, A.M. Schumacher, B.J. Abbott, Protocols for Screening Chemical Agents and Natural Products Against Animal Tumours and Other Biological Systems, third ed., National Cancer Institute, Bethesda, MD, 1972.
45. Greenwood F.C., Hunter W.M., Glover J.S. Biochem. J. 89:1963;114.
46. Labarre P., Papon J., Moreau M.F., Madelmont J.C., Veyre A. Eur. J. Nucl. Med. 25:1998;109-114.